About InterAct Therapeutics
InterAct Therapeutics is a private company based in Dallas, Texas, incorporated in 2025 in Delaware. It has reported $250,000 raised in one offering on Form D since July 2026. Its chief executive is Daniel Hargrove.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Jul 21, 2026 | $250,000of $2.0M target | 1 | $250K | DebtRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on InterAct Therapeutics's Form D filed Jul 21, 2026.
